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Antimicrobial susceptibility testing of Clostridium difficile using EUCAST
epidemiological cut-off values and disk diffusion correlates
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Abstract
With the emergence of reduced susceptibility of Clostridium difficile to metronidazole and vancomycin the value of antimicrobial suscept-
ibility testing has increased. The aim of our study was to evaluate disk diffusion for susceptibility testing of C. difficile by comparing disk
diffusion results with MICs from gradient tests and to propose zone diameter breakpoint correlates for the EUCAST epidemiological
cut-off values (ECOFFs) recently published. We tested 211 clinical isolates of C. difficile, from patients with diarrhoea hospitalized at
Aarhus and Odense University Hospitals, Denmark. Furthermore, ten clinical isolates of C. difficile from the Anaerobe Reference
Laboratory, University Hospital of Wales, with known reduced susceptibility to either metronidazole or vancomycin, were included. Iso-
lates were tested with Etest gradient strips and disk diffusion towards metronidazole, vancomycin and moxifloxacin on Brucella Blood
Agar supplemented with hemin and vitamin K. We found an excellent agreement between inhibition zone diameter and MICs. For each
MIC value, the inhibition zones varied from 0 to 8 mm, with 93% of values within 6 mm for metronidazole, 95% of values within 4 mm
for vancomycin, and 98% of values within 4 mm for moxifloxacin. With proposed zone diameter breakpoints for metronidazole, vanco-
mycin and moxifloxacin of WT ‡ 23 mm, WT ‡ 19 and WT ‡ 20 mm, respectively, we found no very major errors and only major
errors below 2%. In conclusion, we suggest that disk diffusion is an option for antimicrobial susceptibility testing of C. difficile.
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases
ONLINE-ONLY ORIGINAL ARTICLE BACTERIOLOGY
